---











NEVADA                                      
11-2647209                                
(State or other jurisdiction of                         
(IRS Employer
                                
incorporation or organization)                          
Identification No.)



Registrant's telephone number including area code						(801) 424-3555



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section
13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter
period that the registrant was required to file such reports)

Yes X	No

and (2) has been subject to such filing requirements for the past 90 days.

Yes X	No



---

**ITEM 1 - FINANCIAL STATEMENTS**

The condensed financial statements included herein have been prepared by the Company,
pursuant to the rules and regulations of the Securities and Exchange Commission.

In the opinion of the Company, all adjustments, consisting of only normal recurring
adjustments, necessary to present fairly the financial position of the Company as of December 31,
2002 and the results of its operations and changes in its financial position from September 30, 2002
through December 31, 2002 have been made.  The results of its operations for such interim period
is not necessarily indicative of the results to be expected for the entire year.

---



|                                                                                                                                   | December 31,


2002 | September 30,


2002
|---------------------------------------------------------------------------------------------------------------------------------- | ------------------- | --------------------
|**Assets**                                                                                                                        
|Current Assets                                                                                                                     |                     |                     
|Cash                                                                                                                               | $	63                | $	63                
|Interest Receivable                                                                                                                | 7,289               | 3,391               
|Note Receivable                                                                                                                    | 195,000             | 195,000             
|Total Assets                                                                                                                       | $	202,352           | $	198,454           
|                                                                                                                                   |                     |                     
|**Liabilities and Stockholders' Equity**                                                                                          
|Current Liabilities                                                                                                                |                     |                     
|Accounts Payable                                                                                                                   | $	6,627             | $	79,627            
|Taxes Payable                                                                                                                      | 3,200               | 2,400               
|Interest Payable                                                                                                                   | 11,756              | 7,271               
|Notes Payable                                                                                                                      | 293,010             | 220,010             
|Total Current Liabilities                                                                                                          | 314,593             | 309,308             
|                                                                                                                                   |                     |                     
|Stockholders' Equity                                                                                                               |                     |                     
|Common Stock 100,000,000 shares authorized at $.001 par
value; 2,256,594 and 25,000,000 shares respectively issued
and outstanding | 2,257               | 2,257               
|Additional Paid In Capital                                                                                                         | 293,885             | 293,885             
|Retained Deficit                                                                                                                   | (408,383)           | (406,996)           
|                                                                                                                                   |                     |                     
|Total Stockholders' Equity                                                                                                         | (112,241)           | (110,854)           
|Total Liabilities and Stockholders' Equity                                                                                         | $	202,352           | $	198,454           

---

**MedXLink, Corp.**

|                                     | For the Three Months Ended
|------------------------------------ | --------------------------
|                                     | December 31, 2002         
|Revenue                              | $           -             
|                                     |                           
|Expenses                             |                           
|General & Administrative             | -                         
|Total Expenses                       | -                         
|Loss from Operations                 | -                         
|Other Income (Expenses)              |                           
|Interest Income                      | 3,900                     
|Interest Expense                     | (4,784)                   
|Total Other Income  (Expenses)       | (884)                     
|Taxes                                | 800                       
|Net Income (Loss)                    | $	(1,684)                 
|                                     |                           
|Loss per Common  Share               | $-                        
|Weighted Average  Outstanding Shares | 2,256,594                 

---

******MedXLink, Corp.**Statement of Cash Flows
(Unaudited)

|                                                 | For the Three Months Ended
|------------------------------------------------ | --------------------------
|                                                 | December 31, 2002         
|Cash Flows from Operating Activities             |                           
|Net Income (Loss)                                | $	(1,684)                 
|Adjustments to Reconcile Net (Loss) to Net Cash; |                           
|(Increase) in Interest Receivable                | (3,900)                   
|Increase in Interest Payable                     | 4,784                     
|Increase in Taxes Payable                        | 800                       
|Net Cash Provided (Used) by Operating Activities | -                         
|                                                 |                           
|Cash Flows from Investing Activities             |                           
|(Increase) in Note Receivable                    | -                         
|Net Cash Provided (Used) by Investing Activities | -                         
|Cash Flows from Financing Activities             |                           
|Proceeds from Sale of Stock                      | -                         
|Proceeds from Note Payable                       | -                         
|Net Cash Provided (Used) by Financing Activities | -                         
|                                                 |                           
|Increase (Decrease) in Cash                      | -                         
|Cash, Beginning of Period                        | 63                        
|Cash, End of Period                              | $	63                      
|                                                 |                           
|Supplemental Cash Flow Information               |                           
|Interest                                         | $-                        
|Income Taxes (Including Penalties & Interest)    | -                         

---





NOTE 1 - Interim Financial Statements

The financial statements for the three months ended December 31, 2002 were prepared from the
books and records of the company.  Management believes that all adjustments have been made to
the financial statements to make a fair presentation of the financial condition of the company as of
December 31, 2002.  The results of the three months are not indicative of a full year of operation for
the Company.

Certain information and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles, in the United States of America, have been
condensed or omitted.  It is suggested that these financial statements be read in conjunction with the
financial statements and notes thereto included in the Company's September 30, 2002 audited
financial statements.  The results of operations for the periods ended December 31, 2002 are not
necessarily indicative of the operating results for the full year.

**ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS.**

Liquidity and Capital Resources.  The Registrant had approximately $(112,241) as operating
capital at December 31, 2002, compared to $(110,854) for the same period last year. The Registrant
intends to raise additional funds as needed through private placements with accredited and
sophisticated investors.

Results of Operation.  Due to the lack of operations during the quarter ended December 31,
2002, the registrant had net loss of $1,684 compared to net loss of $1,792 for the same period last
year.

Plan of Operations.  The Company is currently in the process of looking for business
opportunities to acquire or merge with.  There is no guarantee that management will be successful
in finding such an opportunity.  The Company is also in the process of bringing all of its periodic
reports current for filing with the Securities and Exchange Commission. During this process, the
Company intends to raise operational capital through private placements.

---



**ITEM 3 - CONTROLS AND PROCEDURES.**

(a) Evaluation of disclosure controls and procedures.  The Company's principal executive
officer and its principal financial officer, based on their evaluation of the Company's disclosure
controls and procedures (as defined in Exchange Act Rules 13a-14 (c) as of a date within 90 days
prior to the filing of this Quarterly Report on Form 10-QSB, have concluded that the Company's
disclosure controls and procedures are adequate and effective for the purposes set forth in the
definition in Exchange Act rules.

(b) Changes in internal controls.  There were no significant changes in the Company's
internal controls or in other factors that could significantly affect the Company's internal controls
subsequent to the date of their evaluation.

---





**OTHER INFORMATION**

Item 1.	Legal Proceedings

None

Item 2.	Changes in Securities

None

Item 3.	Defaults Upon Senior Securities

None

Item 4.	Submission of Matters to a Vote of Security Holders

None

Item 5.	Other Information

None

Item 6.	Exhibits and Reports on Form 8-K

None

---





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned authorized officer.

Dated: February 14, 2003

**MedXLink, Corp.**

/S/ Dean BeckerDean Becker

---

**SECTION 302 CERTIFICATION**

I, Dean Becker, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of MedXLink, Corp;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this quarterly report.

3.  Based on my knowledge, the financial statements, and other financial information included
in this quarterly report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this quarterly
report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) Designed such disclosure controls and procedures to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this quarterly report is
being prepared.

b) Evaluated the effectiveness of the registrant's disclosure controls and procedures as of a
date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date");
and

c) Presented in this quarterly report our conclusions about the effectiveness of the disclosure
controls and procedures based on our evaluation as of the Evaluation Date;

5. I have disclosed, based on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies in the design or operation of internal controls which could
adversely affect the registrant's ability to record, process, summarize and report financial data
and have identified for the registrant's auditors any material weaknesses in internal controls;
and

b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls; and

6.  I have indicated in this quarterly report whether or not there were significant changes in
internal controls or in other factors that could significantly affect internal controls subsequent to the
date of our most recent evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

Date: February 10, 2003

s/Dean Becker
Chief Executive Officer
And Principle Accounting Officer

---





In connection with the Quarterly Report of MedXLink, Corp, on Form 10-QSB for the period
ending December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof
(the *"Report"*), the undersigned, Dean Becker, Chief Executive Officer and Principle Accounting
Officer  of the Company, certify, pursuant to 18 U.S.C.  1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company.

Date: February 10, 2003

Dean Becker,
Chief Executive Officer
And Principle Accounting Officer

---